Navin Fluorine International Limited has announced the commencement of commercial production at its new cGMP-4 plant located in Dewas. This follows the successful validation of initial batches with their European partner. The company informed stakeholders of this development via a press release issued on December 31, 2025. This expansion aims to bolster Navin Fluorine’s production capabilities and market presence.
New Facility Operational
Navin Fluorine International Limited announced that commercial production has commenced at its new cGMP-4 plant located in Dewas. This development marks a significant step in expanding the company’s manufacturing capabilities.
Validation and Commencement
The start of production follows the successful validation of batches at the Dewas plant in collaboration with Navin Fluorine’s European partner. The announcement was made on December 31, 2025, signaling the beginning of commercial operations at Phase 1 of the facility.
Source: BSE
